Holen Sie sich die Stockscreener-App
3.915
0.38%
-0.025
Schlusskurs vom Vortag:
$3.94
Offen:
$3.85
24-Stunden-Volumen:
600.41K
Relative Volume:
0.68
Marktkapitalisierung:
$498.72M
Einnahmen:
$193.01M
Nettoeinkommen (Verlust:
$-12.15M
KGV:
-43.50
EPS:
-0.09
Netto-Cashflow:
$454.00K
1W Leistung:
-6.55%
1M Leistung:
-1.13%
6M Leistung:
+1.68%
1J Leistung:
-24.52%
1-Tages-Spanne:
$3.82
$3.985
1-Wochen-Bereich:
$3.705
$4.22
52-Wochen-Spanne:
$2.37
$7.63
Cytek Biosciences Inc Stock (CTKB) Company Profile
Firmenname
Cytek Biosciences Inc
Sektor
Branche
Telefon
(877) 922-9835
Adresse
47215 LAKEVIEW BOULEVARD, FREMONT
Vergleichen Sie CTKB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
3.92 | 501.26M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
125.51 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.94 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
363.46 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.28 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.15 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-09 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-31 | Herabstufung | Goldman | Buy → Sell |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-07-19 | Eingeleitet | Raymond James | Mkt Perform |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
Cytek Biosciences Inc Aktie (CTKB) Neueste Nachrichten
What To Expect From Cytek Biosciences Inc (CTKB) Q3 2025 Earnings - GuruFocus
Why Cytek Biosciences Inc. stock could be next big winnerJuly 2025 Action & Weekly Top Stock Performers List - newser.com
Can Cytek Biosciences Inc. (8EQ) stock sustain revenue momentumEarnings Risk Report & Free Real-Time Volume Trigger Notifications - newser.com
Comparing Cytek Biosciences Inc. in custom built stock radarsEarnings Trend Report & Breakout Confirmation Alerts - newser.com
How Cytek Biosciences Inc. stock reacts to bond yields2025 EndofYear Setup & Fast Entry High Yield Tips - newser.com
Applying Elliott Wave Theory to Cytek Biosciences Inc.2025 Volatility Report & AI Powered Market Trend Analysis - newser.com
Multi factor analysis applied to Cytek Biosciences Inc.Index Update & Risk Controlled Daily Trade Plans - newser.com
How supply chain issues affect Cytek Biosciences Inc. stockRisk Management & Free Community Consensus Stock Picks - newser.com
Is Cytek Biosciences Inc. (8EQ) stock overpriced at current multiplesJuly 2025 Summary & Proven Capital Preservation Methods - newser.com
Is Cytek Biosciences Inc. stock supported by innovation pipelineMarket Risk Analysis & Safe Entry Zone Tips - newser.com
Can Cytek Biosciences Inc. stock maintain growth trajectoryQuarterly Profit Summary & Weekly Top Performers Watchlists - newser.com
Does Cytek Biosciences Inc. stock trade at a discount to peersWeekly Risk Report & Capital Efficiency Focused Strategies - newser.com
Can a trend reversal in Cytek Biosciences Inc. lead to recovery - newser.com
Smart tools for monitoring Cytek Biosciences Inc.’s price actionGold Moves & Short-Term Trading Alerts - newser.com
Will Cytek Biosciences Inc. (8EQ) stock beat growth indexesJuly 2025 Recap & Technical Buy Zone Confirmations - newser.com
Understanding Cytek Biosciences Inc.’s price movementJuly 2025 PostEarnings & Verified Trade Idea Suggestions - newser.com
How strong dollar benefits Cytek Biosciences Inc. (8EQ) stockQuarterly Portfolio Review & Proven Capital Preservation Methods - newser.com
Finanzdaten der Cytek Biosciences Inc-Aktie (CTKB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cytek Biosciences Inc-Aktie (CTKB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| McCombe William D. | Chief Financial Officer |
Jun 02 '25 |
Buy |
2.78 |
35,000 |
97,300 |
55,746 |
1.22%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):